Status:
COMPLETED
Safety Study of Abatacept to Treat Rheumatoid Arthritis
Lead Sponsor:
Bristol-Myers Squibb
Collaborating Sponsors:
Arthritis Research Centre of Canada
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to compare the incidence rates of infection, malignancy and death among patients with rheumatoid arthritis who are treated with abatacept and those who are treated with ot...
Eligibility Criteria
Inclusion
- Rheumatoid arthritis
- Receipt of abatacept, other biologic disease-modifying drug, or any non- biologic disease-modifying anti-rheumatic drug
- Age 18 years or older
Exclusion
- Below 18 years of age
Key Trial Info
Start Date :
December 31 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2014
Estimated Enrollment :
6367 Patients enrolled
Trial Details
Trial ID
NCT01247766
Start Date
December 31 2010
End Date
December 31 2014
Last Update
March 21 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.